See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2017_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,518,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,330,000 |
| 3 | remainder_Assets | 18,000 |
| 4 | LiabilitiesCurrent | 10,678,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,792,000 |
| 9 | ResearchAndDevelopmentExpense | 20,929,000 |
| 10 | remainder_Expenses | -863,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 117,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,866,000 |
| 1 | Liabilities | 10,678,000 |
| 2 | Expenses | 28,858,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 53,188,000 |
| 5 | NetIncome | -28,741,000 |
| 6 | ComprehensiveNetIncome | -28,741,000 |
| 7 | BaseVar | 51,759,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.34 |
| 9 | EconomicCapitalRatio | 3.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
